104 related articles for article (PubMed ID: 6473153)
1. Morphological and functional correlates of VIP neurons in cerebral cortex.
Magistretti PJ; Morrison JH; Shoemaker WJ; Bloom FE
Peptides; 1984; 5(2):213-8. PubMed ID: 6473153
[TBL] [Abstract][Full Text] [Related]
2. The effects of VIP on cyclic AMP and glycogen levels in vertebrate retina.
Schorderet M; Hof P; Magistretti PJ
Peptides; 1984; 5(2):295-8. PubMed ID: 6089132
[TBL] [Abstract][Full Text] [Related]
3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
4. Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and adenohypophysis.
Magistretti PJ; Schönenberg P; Kehrer P; Martin JL; Gaillard RC
Peptides; 1986; 7 Suppl 1():175-80. PubMed ID: 3018695
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.
Magistretti PJ; Morrison JH; Shoemaker WJ; Sapin V; Bloom FE
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6535-9. PubMed ID: 6118864
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuropeptides of the secretin/VIP/PACAP family on cyclic AMP formation in the chick hypothalamus and cerebral cortex.
Nowak JZ; Kuba K; Zawilska JB
Pol J Pharmacol; 2000; 52(6):467-71. PubMed ID: 11334241
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes.
Sorg O; Magistretti PJ
Brain Res; 1991 Nov; 563(1-2):227-33. PubMed ID: 1664773
[TBL] [Abstract][Full Text] [Related]
8. Acute stimulation of ganglionic tyrosine hydroxylase activity by secretin, VIP and PHI.
Ip NY; Baldwin C; Zigmond RE
Peptides; 1984; 5(2):309-12. PubMed ID: 6147816
[TBL] [Abstract][Full Text] [Related]
9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
[TBL] [Abstract][Full Text] [Related]
11. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
[TBL] [Abstract][Full Text] [Related]
12. Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase in the rat superior cervical ganglion.
Ip NY; Ho CK; Zigmond RE
Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7566-9. PubMed ID: 6130526
[TBL] [Abstract][Full Text] [Related]
13. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
[TBL] [Abstract][Full Text] [Related]
15. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide and PHI stimulate somatostatin release from rat cerebral cortical and diencephalic cells in dispersed cell culture.
Tapia-Arancibia L; Reichlin S
Brain Res; 1985 Jun; 336(1):67-72. PubMed ID: 2860951
[TBL] [Abstract][Full Text] [Related]
17. The distribution and morphological characteristics of the intracortical VIP-positive cell: an immunohistochemical analysis.
Morrison JH; Magistretti PJ; Benoit R; Bloom FE
Brain Res; 1984 Feb; 292(2):269-82. PubMed ID: 6362778
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
Couvineau A; Gammeltoft S; Laburthe M
J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
[TBL] [Abstract][Full Text] [Related]
19. Intercellular communication mediated by VIP in the cerebral cortex.
Magistretti PJ
Peptides; 1986; 7 Suppl 1():169-73. PubMed ID: 2875443
[TBL] [Abstract][Full Text] [Related]
20. Concentrations and distribution of vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI) and peptide histidine valine (PHV) in the cerebral cortex and the suprachiasmatic nucleus of the mouse.
Mikkelsen JD; Fahrenkrug J
Brain Res; 1994 Sep; 656(1):95-107. PubMed ID: 7804850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
